Disease burden of congenital cytomegalovirus infection in Japan

Hirosato Aoki1, Taito Kitano2, Daisuke Kitagawa3

  • 1Department of Neonatology, Kanagawa Children's Medical Center, 2-138-4 Mutsukawa, Minami-ku, Yokohama, Kanagawa, 232-8555, Japan.

Insights

Congenital cytomegalovirus infection imposes a significant lifetime economic burden in Japan, estimated at 27.6 billion JPY in 2019. This highlights the need for national screening and early treatment strategies.

Area of Science:

  • Public Health
  • Health Economics
  • Infectious Diseases

Background:

  • Congenital cytomegalovirus (CMV) is a leading cause of congenital infections and newborn malformations in developed nations.
  • Despite global discussions on neonatal screening and treatment, data on the lifetime economic impact of congenital CMV is limited.
  • Understanding the economic burden is crucial for evaluating the cost-effectiveness of potential interventions.

Purpose of the Study:

  • To calculate the lifetime economic and health burdens associated with congenital cytomegalovirus infection in Japan.
  • To inform national strategies regarding neonatal screening and early treatment for congenital CMV.

Main Methods:

  • Economic and lifetime health burdens were estimated for the 2019 Japanese annual birth cohort.
  • Data utilized included demographic, epidemiologic, health value, and economic indicators.
  • The economic burden was categorized into medical and social costs, with sensitivity analysis performed.

Main Results:

  • The estimated total economic burden of congenital CMV infection in Japan for 2019 was 27.6 billion JPY.
  • Acute care medical costs represented a minor component of the overall economic burden.
  • Social costs significantly outweighed medical costs, indicating a substantial societal impact.

Conclusions:

  • The study quantifies the considerable economic burden of congenital CMV infection in Japan.
  • Findings underscore the disease's significance and provide valuable data for guiding national public health policies.
  • Results support the implementation of neonatal screening and early treatment programs to mitigate long-term costs.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.3K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
601
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
106.9K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
290